Enhancing Family Based Treatment of Childhood Obesity Through Social Networks
NCT ID: NCT02206529
Last Updated: 2017-10-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2012-05-31
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Social Network Engagement+Std Treatment
Social Network Engagement = content and activities to help the parent engage his/her social network in supporting healthy lifestyle behaviors.
Standard Treatment = family-based behavioral pediatric obesity treatment, as per protocol outlined in FOCUS trial (Family Overweight: Comparing Use of Strategies; NCT00746629)
Social Network Engagement+Std Treatment
Standard Treatment
This comparator arm consists of historical controls, participants in the FOCUS trial who received standard treatment.
Standard Treatment = family-based behavioral pediatric obesity treatment, as per protocol outlined in FOCUS trial (Family Overweight: Comparing Use of Strategies; NCT00746629)
Standard Treatment
Standard Treatment = family-based behavioral pediatric obesity treatment, as per protocol outlined in FOCUS trial (Family Overweight: Comparing Use of Strategies; NCT00746629)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Social Network Engagement+Std Treatment
Standard Treatment
Standard Treatment = family-based behavioral pediatric obesity treatment, as per protocol outlined in FOCUS trial (Family Overweight: Comparing Use of Strategies; NCT00746629)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At or above the 85th percentile for age- and gender-specific BMI
Parents
• At least one overweight parent (BMI\>25.0)
Parents and children
* English-speaking and at least at a second-grade reading level
* Live \<50 miles from the treatment site.
Exclusion Children
* Conditions known to promote obesity (e.g., Prader-Willi),
* Participation in another weight control program
* Recently started taking weight-affecting medications (e.g., stimulants).
Parents and children
* Disability or illness that would preclude them from engaging in at least moderate-intensity physical activity,
* Current or prior diagnosed eating disturbance
* Thought disorder, suicidality, or substance abuse disorder
7 Years
13 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kaiser Permanente
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paula Lozano, MD MPH
Role: PRINCIPAL_INVESTIGATOR
Group Health Research Institute
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
211098
Identifier Type: -
Identifier Source: org_study_id